J, H., JJ, H., M, M., CJ, N., MC, B., TN, T., . . . M, A. (2018). Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. The Journal of clinical investigation, 128(10), 4654. https://doi.org/10.1172/JCI99317
Chicago Style (17th ed.) CitationJ, Hsu, et al. "Contribution of NK Cells to Immunotherapy Mediated by PD-1/PD-L1 Blockade." The Journal of Clinical Investigation 128, no. 10 (2018): 4654. https://doi.org/10.1172/JCI99317.
MLA (9th ed.) CitationJ, Hsu, et al. "Contribution of NK Cells to Immunotherapy Mediated by PD-1/PD-L1 Blockade." The Journal of Clinical Investigation, vol. 128, no. 10, 2018, p. 4654, https://doi.org/10.1172/JCI99317.
Warning: These citations may not always be 100% accurate.